<?xml version="1.0" encoding="UTF-8"?>
<p id="p0125">As shown in 
 <xref rid="fig1" ref-type="fig">FigureÂ 1</xref>, only adult patients with mild MPS II who were able to describe their subjective symptoms were deemed appropriate for part 1 of the study, which was designed to confirm the safety of JR-141. On this basis, only two subjects were selected.
</p>
